Drug-Free Workplace Policy (Philippines)
DRUG-FREE WORKPLACE POLICY
Republic Act 9165 (Comprehensive Dangerous Drugs Act of 2002) | DOLE Department Order No. 53-03
Company: [Company Name]
Address: [Company Address]
Effective Date: [Effective Date]
1. POLICY STATEMENT
[Company Name] is committed to maintaining a drug-free workplace for the safety, health, and productivity of all employees. The use, possession, distribution, or sale of dangerous drugs listed under the Schedules to Republic Act 9165 (Comprehensive Dangerous Drugs Act of 2002) in the workplace is strictly prohibited. This Policy is issued in compliance with RA 9165 and DOLE Department Order No. 53-03 (Guidelines for the Implementation of a Drug-Free Workplace Policies and Programs for the Private Sector).
Signed by: [CEO Name], Chief Executive Officer / General Manager, [Company Name]
2. PROHIBITED CONDUCT
The following conduct is strictly prohibited on company premises, in company vehicles, or during work hours or work-related activities:
2.1 Use, possession, or being under the influence of methamphetamine hydrochloride (shabu), cannabis (marijuana), cocaine, MDMA (ecstasy), or any other dangerous drug listed in the Schedules to RA 9165.
2.2 Sale, trading, distribution, or facilitation of the distribution of dangerous drugs.
2.3 Reporting for work while impaired by drugs or alcohol to a degree that affects job performance or safety.
2.4 Refusal to submit to a required drug test under this Policy.
3. DRUG TESTING PROGRAM
3.1 [Company Name] shall conduct random drug testing [Testing Frequency], conducted by [Drug Testing Center], a DOH-accredited drug testing center under DOH Administrative Order No. 2008-0009.
3.2 Urine samples shall be collected following DOH chain of custody protocols. Positive screening results shall be confirmed by gas chromatography/mass spectrometry (GC/MS) before any action is taken.
3.3 An employee who receives a positive confirmed result may request a second confirmatory test at another DOH-accredited laboratory within 15 days of notification, at the employee's expense.
3.4 All drug test results are confidential under Section 72 of RA 9165 and the Data Privacy Act (RA 10173). Results shall only be disclosed to authorized HR personnel and the concerned employee.
4. EMPLOYEE ASSISTANCE PROGRAM (EAP)
4.1 [Company Name] encourages employees with substance abuse issues to seek help voluntarily. Employees who voluntarily disclose a substance abuse problem before being required to undergo drug testing may be referred to the Employee Assistance Program at [EAP Provider] without immediate disciplinary action, subject to compliance with treatment and follow-up requirements.
4.2 For first-time confirmed positive test results (excluding possession, sale, or distribution), the Company may, at its discretion, suspend the employee and require enrollment in a DOH-accredited drug treatment and rehabilitation program as an alternative to immediate dismissal, consistent with DOLE Department Order No. 53-03.
5. DISCIPLINARY CONSEQUENCES
5.1 Confirmed positive drug test results or drug-related conduct violations may result in disciplinary action up to and including dismissal for just cause under Article 297(a) of the Labor Code (serious misconduct), following the twin-notice rule.
5.2 Possession, sale, distribution, or facilitation of dangerous drugs in the workplace constitutes an offense warranting immediate dismissal, independent of criminal proceedings under RA 9165.
5.3 Criminal prosecution under RA 9165 may be pursued independently of administrative disciplinary proceedings.
CEO / General Manager
________________
Signature
HR Manager
________________
Signature
What Is a Drug-Free Workplace Policy (Philippines)?
A Drug-Free Workplace Policy in the Philippines records the organisation's position on the matter, defining what is permitted, what is prohibited and how breaches are handled.
Under Section 36 of RA 9165, random drug testing is authorized for officers and employees of public and private offices, with testing to be conducted by accredited drug testing centers. DOLE Department Order No. 53-03 operationalizes this requirement in the private sector by requiring covered establishments to formulate and implement a drug-free workplace policy as a mandatory component of their labor standards compliance. The policy must be submitted to the DOLE Regional Office and posted conspicuously in the workplace. The Philippine Drug Enforcement Agency (PDEA), established under Section 84 of RA 9165, coordinates with DOLE on enforcement of drug-free workplace requirements.
Drug testing under DO 53-03 must be conducted by duly accredited drug testing centers — accredited by the Department of Health (DOH) under Administrative Order No. 2008-0009 — using urine-based immunoassay screening confirmed by gas chromatography/mass spectrometry (GC/MS) as required under DOH drug testing protocols. Employees who test positive for dangerous drugs listed under the Schedules to RA 9165 — including methamphetamine hydrochloride (shabu), cannabis (marijuana), cocaine, and MDMA — are subject to both administrative and criminal consequences.
The confidentiality of drug test results is protected under both RA 9165 and the Data Privacy Act (RA 10173, 2012). Section 72 of RA 9165 prohibits unauthorized disclosure of drug test results, and the National Privacy Commission (NPC) has confirmed that drug test results constitute sensitive personal information under the Data Privacy Act, requiring appropriate security measures and limitation of access to those with a need to know.
The legal framework governing the Drug-Free Workplace Policy (Philippines) in Philippines draws on several key statutes and regulatory bodies. Under Philippine law, the Civil Code of the Philippines (Republic Act No. 386) governs contractual obligations. The Revised Corporation Code (Republic Act No. 11232) regulates corporate entities through the Securities and Exchange Commission (SEC). The Labor Code of the Philippines (Presidential Decree No. 442) and Department of Labor and Employment (DOLE) govern employment matters. The Data Privacy Act of 2012 (Republic Act No. 10173) and the National Privacy Commission (NPC) protect personal data. The Bureau of Internal Revenue (BIR) administers tax obligations under the National Internal Revenue Code. Parties executing a Drug-Free Workplace Policy (Philippines) in Philippines should confirm the document reflects current law, including any amendments enacted since the original drafting date. The Labor Code of the Philippines (PD 442) sets the foundational requirements.
When Do You Need a Drug-Free Workplace Policy (Philippines)?
A Drug-Free Workplace Policy is needed in the Philippines in the following situations.
A Drug-Free Workplace Policy is mandatory for all private-sector establishments with ten or more workers under DOLE Department Order No. 53-03 and Section 36 of Republic Act 9165. Such establishments must formulate and implement the policy within six months of reaching the ten-worker threshold and must submit a copy to the DOLE Regional Office.
A Drug-Free Workplace Policy is required for safety-sensitive industries — such as transportation (LTFRB), construction, mining, oil and gas, and manufacturing — where impairment due to dangerous drugs or alcohol poses direct physical risks to workers and the public, making a written policy a prerequisite for operating permits and DOLE certification.
A Drug-Free Workplace Policy is needed when an employer conducts pre-employment drug testing as a condition of hiring, to provide the legal basis for the testing and the consequences of a positive result under RA 9165 and the employer's disciplinary procedures.
A Drug-Free Workplace Policy is required when an employer implements random drug testing programs during employment, to document the testing frequency, selection methodology (random computerized selection), employee rights (to request confirmation testing), and confidentiality protections.
A Drug-Free Workplace Policy is needed when an employer wishes to offer rehabilitation assistance to employees with substance abuse issues, as DOLE Department Order No. 53-03 encourages employers to provide Employee Assistance Programs (EAP) as an alternative to immediate dismissal for first-time offenders.
Parties in Philippines should prepare a Drug-Free Workplace Policy (Philippines) proactively rather than waiting for a dispute to arise. Courts interpret agreements based on the written terms rather than oral representations. Under Philippine law, the Civil Code of the Philippines (Republic Act No. 386) governs contractual obligations. The Revised Corporation Code (Republic Act No. 11232) regulates corporate entities through the Securities and Exchange Commission (SEC). The Labor Code of the Philippines (Presidential Decree No. 442) and Department of Labor and Employment (DOLE) govern employment matters. The Data Privacy Act of 2012 (Republic Act No. 10173) and the National Privacy Commission (NPC) protect personal data. The Bureau of Internal Revenue (BIR) administers tax obligations under the National Internal Revenue Code. Where the transaction involves regulated activities, prior approval from the relevant authority may be required before execution.
What to Include in Your Drug-Free Workplace Policy (Philippines)
A valid Philippines Drug-Free Workplace Policy contains the following essential elements.
Policy Statement: Declaration of the establishment's commitment to a drug-free workplace under RA 9165 and DOLE Department Order No. 53-03, signed by the top management officer.
Scope and Coverage: All employees — regular, probationary, project-based, and casual — as well as contractors and visitors on company premises, with specification of safety-sensitive positions subject to more frequent testing.
Prohibited Conduct: Specific prohibition on use, possession, distribution, selling, or being under the influence of dangerous drugs listed in the Schedules to RA 9165 (including methamphetamine, cannabis, cocaine, MDMA, and others) on company premises, company vehicles, or during work hours.
Drug Testing Procedures: Description of the random drug testing program — including the frequency (typically once per year per DOLE DO 53-03), selection methodology (random computerized selection by the accredited DOH testing center), the accredited testing center used, urine collection procedures, chain of custody protocols, and confirmation testing by GC/MS for positive results.
Employee Rights: The employee's right to request a confirmatory test at the same or another DOH-accredited laboratory within 15 days of notification of a positive result, at the employee's expense.
Employee Assistance Program (EAP): Availability of counseling, referral to government-accredited drug treatment and rehabilitation centers, and the employer's policy on temporary suspension versus dismissal for first-time positive results.
Disciplinary Consequences: Range of sanctions from suspension to dismissal for just cause under Article 297(a) of the Labor Code (serious misconduct) for confirmed positive drug test results or drug-related conduct violations.
Confidentiality: Commitment to maintain the confidentiality of drug test results under Section 72 of RA 9165 and the Data Privacy Act (RA 10173).
Additional compliance elements for a Drug-Free Workplace Policy (Philippines) used in Philippines include: Under Philippine law, the Civil Code of the Philippines (Republic Act No. 386) governs contractual obligations. The Revised Corporation Code (Republic Act No. 11232) regulates corporate entities through the Securities and Exchange Commission (SEC). The Labor Code of the Philippines (Presidential Decree No. 442) and Department of Labor and Employment (DOLE) govern employment matters. The Data Privacy Act of 2012 (Republic Act No. 10173) and the National Privacy Commission (NPC) protect personal data. The Bureau of Internal Revenue (BIR) administers tax obligations under the National Internal Revenue Code. Forms-legal.com provides this template as a starting point for Philippines-compliant documentation. For Philippine employers covered by RA 9165 and DOLE Department Order No. 53-03 — all private-sector establishments with ten or more workers — implementing and maintaining a written Drug-Free Workplace Policy is a mandatory labor standards obligation enforced by the DOLE Regional Office through the Labor Inspection Program. The forms-legal.com Drug-Free Workplace Policy template provides a Philippines-compliant framework for RA 9165 and DO 53-03 compliance.
Cite this page
Reference this free template in an article, syllabus, or research note:
Forms Legal. (2026). Drug-Free Workplace Policy (Philippines) (Philippines) [Legal document template]. Forms Legal. https://forms-legal.com/philippines/employment/hr-forms/drug-free-workplace-policy-philippines
"Drug-Free Workplace Policy (Philippines) (Philippines)." Forms Legal, 2026, https://forms-legal.com/philippines/employment/hr-forms/drug-free-workplace-policy-philippines.
@misc{formslegal-drug-free-workplace-policy-philippines,
author = {{Forms Legal}},
title = {Drug-Free Workplace Policy (Philippines) (Philippines)},
year = {2026},
howpublished = {\url{https://forms-legal.com/philippines/employment/hr-forms/drug-free-workplace-policy-philippines}},
note = {Free legal document template. Based on Labor Code of the Philippines (PD 442)}
}Frequently Asked Questions
Yes, drug testing is mandatory for private-sector establishments with ten or more workers under Section 36(d) of Republic Act 9165 (Comprehensive Dangerous Drugs Act of 2002) and DOLE Department Order No. 53-03. The testing must be random and conducted by a drug testing center accredited by the Department of Health (DOH) under Administrative Order No. 2008-0009. The test uses urine-based immunoassay screening, with positive results confirmed by gas chromatography/mass spectrometry (GC/MS). The Supreme Court of the Philippines upheld the constitutionality of mandatory random drug testing for private employees in SJS v Dangerous Drugs Board (G.R. No. 157870, November 3, 2008), distinguishing it from random testing of students (upheld) versus candidates for public office (struck down as unconstitutional). Employers who fail to implement a drug-free workplace policy and testing program are subject to DOLE compliance orders and fines.
The disciplinary consequences of a positive drug test in the Philippines depend on whether the test is confirmed by GC/MS and the employer's drug-free workplace policy. For a confirmed positive result, the employer may dismiss the employee for just cause under Article 297(a) of the Labor Code (serious misconduct or conduct analogous thereto), provided the twin-notice rule is observed — a Notice to Explain (NTE) and a Notice of Decision after the employee is given an opportunity to respond. However, DOLE Department Order No. 53-03 encourages employers to consider the Employee Assistance Program (EAP) for first-time offenders who test positive for casual use, offering temporary suspension and referral for treatment rather than immediate dismissal. An employee in a safety-sensitive position who tests positive may be removed from that position immediately pending investigation under the employer's drug policy. The employee has the right to request a confirmatory test at their own expense within 15 days of notification of the initial positive result.
A Drug-Free Workplace Policy (Philippines) does not legally require a lawyer in Philippines, and individuals and businesses may draft and execute the document independently. The Labor Code of the Philippines (PD 442) does not mandate legal representation for the creation or signing of this type of document. However, seeking independent legal advice from a qualified Philippines lawyer is recommended for transactions involving substantial financial value, complex regulatory requirements, or cross-border elements where multiple legal jurisdictions may apply. A lawyer can verify that the document complies with all applicable statutory requirements, identify potential risks specific to the transaction, and confirm that the terms adequately protect the interests of all parties involved. The Supreme Court of the Philippines has jurisdiction over disputes arising from this type of document, and Securities and Exchange Commission (SEC Philippines) may impose additional compliance obligations depending on the nature of the underlying transaction. Professional legal review is particularly advisable where the document will be submitted to government agencies or used as evidence in legal proceedings.
When an employee tests positive for dangerous drugs under DOLE Department Order No. 53-03 implementing Republic Act 9165, the Philippine employer must follow a structured response process to comply with labor law and avoid NLRC liability. First, the employer must confirm the positive result through a GC/MS confirmatory test — initial immunoassay screening is not conclusive. The employee has the right under DO 53-03 to request a confirmatory test at the same DOH-accredited laboratory or another accredited facility within 15 days of notification of the initial positive result, at the employee's expense. If the GC/MS confirmatory test is also positive, the employer initiates the twin-notice procedure required for disciplinary action under Article 297 of the Labor Code (PD 442): (1) a Notice to Explain (NTE) giving the employee at least five days to submit a written explanation; followed by (2) a Notice of Decision after considering the employee's response. For first-time offenders, DOLE Department Order No. 53-03 encourages employers to consider the Employee Assistance Program (EAP) — offering rehabilitation through a PDEA-accredited treatment and rehabilitation center — as an alternative to immediate dismissal. Employers who dismiss employees without following the twin-notice rule and procedural due process face potential NLRC claims for illegal dismissal, even if the substantive ground (positive drug test) is valid. The Philippine Drug Enforcement Agency (PDEA) and Department of Health (DOH) coordinate with DOLE on employer compliance. The forms-legal.com Drug-Free Workplace Policy template includes the twin-notice procedure and EAP framework.
Mandatory workplace drug testing under Section 36 of Republic Act 9165 (Comprehensive Dangerous Drugs Act of 2002) and DOLE Department Order No. 53-03 covers all dangerous drugs listed in the Schedules to RA 9165. In practice, the standard DOH-accredited drug test panel for Philippine workplaces screens for: methamphetamine hydrochloride (shabu) — the most prevalent dangerous drug in Philippine law enforcement statistics; cannabis (marijuana); cocaine; opiates including heroin; MDMA (ecstasy); and amphetamines. The Department of Health (DOH) Administrative Order No. 2008-0009 prescribes the technical standards for drug testing: urine-based immunoassay screening followed by gas chromatography/mass spectrometry (GC/MS) confirmation for all reactive specimens. The Philippine Drug Enforcement Agency (PDEA) publishes updates to the list of controlled substances, which may include new synthetic drugs or precursors added by Department of Health and Department of Justice circulars. Alcohol is separately regulated — the Labor Code (PD 442) and company policies address alcohol impairment, while RA 9165 and DO 53-03 focus specifically on dangerous drugs. For safety-sensitive industries such as transportation and construction, the Land Transportation Franchising and Regulatory Board (LTFRB) and the Department of Public Works and Highways (DPWH) may impose more frequent drug testing than the once-a-year minimum under DO 53-03.
This template is provided for informational purposes only and does not constitute legal advice. Laws vary by jurisdiction and change over time. Consult a qualified attorney for advice specific to your situation.Full disclaimer
Found an error? Let us knowRelated Documents
You may also find these documents useful:
Workplace Harassment Policy (Philippines)
A Philippine workplace harassment prevention policy under Republic Act 11313 (Safe Spaces Act / Bawal Bastos Law of 2019) and Republic Act 7877 (Anti-Sexual Harassment Act of 1995), establishing procedures for reporting, investigating, and resolving harassment complaints in the workplace, including gender-based harassment and sexual harassment.
Occupational Health and Safety Policy (Philippines)
A Philippine Occupational Safety and Health (OSH) policy under Republic Act 11058 (OSH Standards Act of 2018) and DOLE Department Order No. 198-18, establishing employer safety commitments, hazard identification, emergency procedures, and compliance with mandatory OSH standards for private-sector establishments.
Workplace Incident Report Form (Philippines)
A Philippine workplace incident report form under Republic Act 11058 (OSH Standards Act of 2018) and DOLE Department Order No. 198-18, for documenting work accidents, near-misses, and occupational illnesses. Supports DOLE Work Accident/Illness Report (WAIR) submission and Employees Compensation Commission (ECC) claims.